20/20 GeneSystems, Inc. finalized its first equity crowdfunding campaign this week with gross proceeds of $1.07 million, the maximum amount permitted under current SEC rules pursuant to Regulation CF. In so doing, the company became only the second medical technology firm to reach this maximum. 20/20 is now listed as one of the “Top 20 Regulation Crowdfunding Campaigns of All Time” by Crowdfund Capital Advisors. The campaign was posted on First Democracy VC, a joint venture between Indiegogo and MicroVentures and was assisted by marketing firm Enventys Partners.
{iframe}https://finance.yahoo.com/news/20-20-closes-record-equity-135200954.html{/iframe}